Statement Of Changes In Equity [Abstract]

Oxford Biomedica PLC - Filing #5242757

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through acquisition of subsidiary, equity
GBP
GBP
GBP
34, 642 GBP
GBP
GBP
34, 642 GBP
GBP
GBP
Decrease (increase) through tax on share-based payment transactions, equity
125,000 GBP
GBP
GBP
125,000 GBP
GBP
125,000 GBP
GBP
GBP
GBP
GBP
GBP
GBP
458,000 GBP
GBP
GBP
458,000 GBP
GBP
458,000 GBP
Increase (decrease) through transactions with owners, equity
83,250,000 GBP
5,044,000 GBP
GBP
83,799,000 GBP
72,188,000 GBP
6,018,000 GBP
549,000 GBP
GBP
GBP
Share issue related cost
2,952,000 GBP
GBP
GBP
2, 952 GBP
2, 952 GBP
GBP
GBP
GBP
GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.